Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: Dexmedetomidine for Improving Emergence Quality in Thyroid Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating dexmedetomidine to improve emergence quality after thyroid surgery; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Bach Mai Hospital | Conditions: Thyroid Diseases | Phase 4 | Status: RECRUITING